Login / Signup

Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines.

Ryan A SmithAakash DesaiJana G HashashMary S HayneyFrancis A FarrayeFreddy Caldera
Published in: Inflammatory bowel diseases (2023)
Keyphrases
  • respiratory syncytial virus
  • patients with inflammatory bowel disease
  • human health
  • risk assessment